VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2004 SESSION

• history | hilite | pdf | print version

045126222
HOUSE BILL NO. 359 Offered January 14, 2004 Prefiled January 12, 2004 A BILL to amend the Code of Virginia by adding in Chapter 2 of Title 32.1 an article numbered 15, consisting of a section numbered 32.1-73.8, relating to preventive pharmaceutical services for certain low-income patients. ---------- Patron-- BaCote ---------- Referred to Committee on Health, Welfare and Institutions ----------

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding in Chapter 2 of Title 32.1 an article numbered 15, consisting of a section numbered 32.1-73.8 as follows:

Article 15. Preventive Pharmaceutical Services For Certain Low-Income Patients.

§ 32.1-73.8. Preventive pharmaceutical services for certain low-income patients.

The Commissioner shall establish, by January 1, 2005, a mechanism whereby any public health clinic operated by a local or district health department that maintains pharmacy services shall continue to provide free or low-cost prescription drugs (on a sliding fee scale) to any low-income patients who do not have any prescription drug benefit and whose primary and specialty health care services have been transferred to a community health clinic delivering free or reduced price services to such patients at the recommendation of the public health clinic. However, any such patients shall be required to obtain prescription drugs from pharmaceutical companies' free or reduced price programs in so far as possible.